PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 9, 2026Медицинский вестник МВД0 citations

Minimal Hepatic Encephalopathy With Cirrhosis of the Liver: Efficiency of Treatment and a Possibility to Predict the Course of the Disease. 12-Month Follow-Up Results

IBI. BAKULINNorth-Western State Medical University named after I.I. MechnikovKIK. IVANOVANorth-Western State Medical University named after I.I. Mechnikov

Key Points

  • To determine the effectiveness of rifaximin-α in treating minimal hepatic encephalopathy in cirrhosis and predict disease progression.
  • Evaluated various rifaximin-α treatment regimens.
  • Followed participants for 12 months.
  • Assessed disease progression and risk of complications.
  • Demonstrated positive outcomes in managing minimal hepatic encephalopathy.
  • Identified effective treatment regimens.
  • Provided insights into predicting complications and disease course.

Abstract

This study is focused on efficiency of various rifaximin-α regimens in order to optimize the treatment and preventive approaches for cirrhosis of the liver with minimal hepatic encephalopathy, as well as to predict the course of the disease and the risk of complications.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

BAKULIN et al. (2024) studied this question.

synapsesocial.com/papers/69897a06f0ec2af6756e8396https://doi.org/10.52341/20738080_2024_133_6_23
Ask AI
Helpful
Bookmark
Share
View Full Paper